Poly (ADP-Ribose) Polymerase Inhibitor, ABT888, Improved Cisplatin Effect in Human Oral Cell Carcinoma

Cisplatin is one of the chemotherapeutic drugs used for the management of oral carcinoma, in which combined therapies are estimated to exert superior therapeutic efficacy compared with monotherapy. It is known that poly(ADP-ribosyl)ation is implicated in a multiplicity of cellular activities, such a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biomedicines
Main Authors: Paterniti, Irene, Scuderi, Sarah Adriana, Casili, Giovanna, Lanza, Marika, Mare, Marzia, Giuffrida, Raffella, Colarossi, Cristina, Portelli, Marco, Cuzzocrea, Salvatore, Esposito, Emanuela
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8301366/
https://ncbi.nlm.nih.gov/pubmed/34356835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9070771
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados